<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>
A 57-year-old man with a 60-pack-year history visits his primary care provider because he wants to quit smoking. He has a history of stable coronary artery disease, peripheral vascular disease, and hypertension. He also has severe obstructive lung disease (forced expiratory volume in 1 second, 39% of the predicted value) with a progressive increase in dyspnea. He has quit smoking and has had numerous relapses; the longest duration of abstinence from smoking was 7 months. Each relapse involved casual smoking to “test himself.” During previous attempts to quit, he has used a nicotine patch, a nicotine inhaler, and sustained-release bupropion. He feels motivated to quit smoking because he recently heard about a new medication to aid in quitting, and he wants to improve his health. The patient and his physician discuss the therapeutic options and agree that varenicline (Chantix) may be an option.
Male, Motivation, Nicotine, Brain, Coronary Artery Disease, Tobacco Use Disorder, Benzazepines, Middle Aged, Receptors, Nicotinic, Pulmonary Disease, Chronic Obstructive, Quinoxalines, Practice Guidelines as Topic, Humans, Smoking Cessation, Nicotinic Agonists, Varenicline
Male, Motivation, Nicotine, Brain, Coronary Artery Disease, Tobacco Use Disorder, Benzazepines, Middle Aged, Receptors, Nicotinic, Pulmonary Disease, Chronic Obstructive, Quinoxalines, Practice Guidelines as Topic, Humans, Smoking Cessation, Nicotinic Agonists, Varenicline
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 112 | |
popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 1% |